The Society for AIDS in Africa (SAA), the custodian and organizer of the International Conference on AIDS and STIs in Africa (ICASA) would like to inform beloved delegates and distinguished key stakeholders that ICASA 2021 will be organized either virtual, in-person or hybrid and all adequate dispositions is being taken to give opportunity once again, to our continent to address challenges to end HIV and strengthen our health system in the era where access to COVID-19 Vaccine is our priority.
The revised Key Dates for the 21st edition of the International Conference on AIDS & STIs in Africa (ICASA 2021) from 6th – 11th December 2021:
ABSTRACTS open 1 March 2021
EARLY REGISTRATION opens 1 March 2021
REGULAR REGISTRATION opens 18 May 2021
SCHOLARSHIP APPLCATIONS open 2 July 2021
For more information visit https://saafrica.org/
Following the successful webinar on data management and data sharing, EDCTP and TGHN invite you to join in a new live webinar focusing on the tools and guidance available in the Protocol Development Toolkit on the EDCTP Knowledge Hub, to support the development of high-quality health research protocols. This webinar will take place on 25 February from 12.30-14.00 CET.
We encourage all EDCTP grantees to join us for this webinar, which is an open event and will be particularly relevant to researchers involved in clinical trials in low-resource settings from both the public and private sector, data managers, development partners, other funders, and public health experts.
More information, the agenda and registration details can be found on the EDCTP website: https://www.edctp.org/event/webinar-produce-high-quality-health-research-protocol/
Registration can be done directly via the following link: https://zoom.us/webinar/register/9016122698721/WN_nedbD11tQ4ydNijKnA8irQ
The Global Forum on TB Vaccines is the world’s largest gathering of stakeholders striving to develop new vaccines to prevent TB. It provides an important and unique opportunity to review the state of the field, share the latest research findings, and identify new and innovative approaches to TB vaccine R&D, with the end goal of developing and deploying new TB vaccines as quickly as possible. The Global Forum program addresses the full spectrum of issues relevant to TB vaccine research and development (R&D), from basic research to clinical trials, manufacturing, regulatory, access, and advocacy.
Due to the ongoing coronavirus pandemic, a Virtual Global Forum on TB Vaccines will be convened from 20 - 22 April 2021. It will provide an overview of the state of the field and recent progress in TB vaccine R&D against the backdrop of the COVID-19 pandemic; and convene researchers, developers, funders and other stakeholders remotely to discuss opportunities and challenges for TB vaccine R&D in these unprecedented times.
To register visit https://tbvaccinesforum.org/register/